| Literature DB >> 26977884 |
Nils Halberg1, Caitlin A Sengelaub2, Kristina Navrazhina2, Henrik Molina2, Kunihiro Uryu2, Sohail F Tavazoie3.
Abstract
Enhanced secretion of tumorigenic effector proteins is a feature of malignant cells. The molecular mechanisms underlying this feature are poorly defined. We identify PITPNC1 as a gene amplified in a large fraction of human breast cancer and overexpressed in metastatic breast, melanoma, and colon cancers. Biochemical, molecular, and cell-biological studies reveal that PITPNC1 promotes malignant secretion by binding Golgi-resident PI4P and localizing RAB1B to the Golgi. RAB1B localization to the Golgi allows for the recruitment of GOLPH3, which facilitates Golgi extension and enhanced vesicular release. PITPNC1-mediated vesicular release drives metastasis by increasing the secretion of pro-invasive and pro-angiogenic mediators HTRA1, MMP1, FAM3C, PDGFA, and ADAM10. We establish PITPNC1 as a PI4P-binding protein that enhances vesicular secretion capacity in malignancy.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26977884 PMCID: PMC5300038 DOI: 10.1016/j.ccell.2016.02.013
Source DB: PubMed Journal: Cancer Cell ISSN: 1535-6108 Impact factor: 31.743